Murphy Declan G, Hall Rohan, Tong Raymond, Goel Rajiv, Costello Anthony J
Department of Urology, Epworth Hospital, Richmond, Victoria, Australia.
ANZ J Surg. 2008 Dec;78(12):1076-81. doi: 10.1111/j.1445-2197.2008.04754.x.
There is increasing patient and surgeon interest in robotic-assisted surgery, particularly with the proliferation of da Vinci surgical systems (Intuitive Surgical, Sunnyvale, CA, USA) throughout the world. There is much debate over the usefulness and cost-effectiveness of these systems. The currently available robotic surgical technology is described. Published data relating to the da Vinci system are reviewed and the current status of surgical robotics within Australia and New Zealand is assessed. The first da Vinci system in Australia and New Zealand was installed in 2003. Four systems had been installed by 2006 and seven systems are currently in use. Most of these are based in private hospitals. Technical advantages of this system include 3-D vision, enhanced dexterity and improved ergonomics when compared with standard laparoscopic surgery. Most procedures currently carried out are urological, with cardiac, gynaecological and general surgeons also using this system. The number of patients undergoing robotic-assisted surgery in Australia and New Zealand has increased fivefold in the past 4 years. The most common procedure carried out is robotic-assisted laparoscopic radical prostatectomy. Published data suggest that robotic-assisted surgery is feasible and safe although the installation and recurring costs remain high. There is increasing acceptance of robotic-assisted surgery, especially for urological procedures. The da Vinci surgical system is becoming more widely available in Australia and New Zealand. Other surgical specialties will probably use this technology. Significant costs are associated with robotic technology and it is not yet widely available to public patients.
患者和外科医生对机器人辅助手术的兴趣日益浓厚,尤其是随着达芬奇手术系统(直观外科公司,美国加利福尼亚州桑尼维尔)在全球的广泛应用。关于这些系统的实用性和成本效益存在诸多争议。本文描述了当前可用的机器人手术技术。回顾了与达芬奇系统相关的已发表数据,并评估了澳大利亚和新西兰手术机器人技术的现状。澳大利亚和新西兰的第一台达芬奇系统于2003年安装。到2006年已安装了4台系统,目前有7台系统在使用。其中大多数位于私立医院。与标准腹腔镜手术相比,该系统的技术优势包括三维视觉、更高的灵活性和更好的人体工程学设计。目前进行的大多数手术是泌尿外科手术,心脏科、妇科和普通外科医生也在使用该系统。在过去4年中,澳大利亚和新西兰接受机器人辅助手术的患者数量增加了五倍。最常见的手术是机器人辅助腹腔镜根治性前列腺切除术。已发表的数据表明,机器人辅助手术是可行且安全的,尽管安装和后续成本仍然很高。机器人辅助手术越来越被接受,尤其是在泌尿外科手术方面。达芬奇手术系统在澳大利亚和新西兰越来越普及。其他外科专科可能也会使用这项技术。机器人技术成本高昂,公众患者还无法广泛使用。